⏳ Fetching live dividend data...
Home › Calculator › CRY Dividend Calculator 2026
Artivion, Inc. · NYSE
Price: $17.88 · Annual div: $0.40/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CRY → $445.8K in 10 years · $19.29/month
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CRY position with:
Real after-tax yield depends on where you live and how you hold CRY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.21% | -0.59% | $221 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.88% | -0.92% | $188 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.77% | -1.03% | $177 / yr |
| 🇬🇧 UK ISA | 0% | 2.21% | -0.59% | $221 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.02% | -0.78% | $202 / yr |
| 🇨🇦 TFSA | 0% | 2.21% | -0.59% | $221 / yr |
| 🇨🇦 CA Taxable | 25% | 1.66% | -1.14% | $166 / yr |
| 🇦🇺 Super (pension) | 15% | 1.88% | -0.92% | $188 / yr |
| 🇦🇺 AU Taxable | 30% | 1.55% | -1.25% | $155 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.63% | -1.17% | $163 / yr |
| 🇫🇷 FR Taxable | 30% | 1.55% | -1.25% | $155 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.40/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CRY pays quarterly — 4 times per year. Next ex-div: TBD.
How CRY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CRY sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2021-06-01 | 4,423 | $29.39 | $130.0K | ||
| A-Award | 2021-06-01 | 4,423 | $29.39 | $130.0K | ||
| A-Award | 2021-06-01 | 4,423 | $29.39 | $130.0K | ||
| M-Exempt | 2021-04-30 | 2,700 | $11.00 | $29.7K | ||
| Sale | 2021-04-30 | 2,700 | $30.00 | $81.0K | ||
| M-Exempt | 2021-04-30 | 2,700 | $11.00 | $29.7K | ||
| F-InKind | 2021-03-12 | 13,092 | $25.05 | $328.0K | ||
| F-InKind | 2021-03-12 | 2,674 | $25.05 | $67.0K | ||
| A-Award | 2021-02-17 | 5,355 | — | — | ||
| A-Award | 2021-02-17 | 15,118 | $24.90 | $376.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CRY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →